STORZ MEDICAL Webinar live »Transcranial Pulse Stimulation (TPS) and Further Treatment Concepts in Patients with Alzheimer’s Disease« mercoledì 14 aprile 2021 ore 18.00 – 19.00 (CET)

2021-04-14-Webinar-Wojtecki

Esistono varie forme di stimolazione cerebrale utilizzate nelle malattie neurodegenerative. In questo webinar il neurologo Dr. Lars Wojtecki parla del contesto scientifico e dei dati clinici della stimolazione transcranica a impulsi, nonché dell’esperienza pratica con la manipolazione e gli effetti clinici. Quale paziente scegliere? Come confrontare la TPS© con la TMS?

Continua a leggere
0
  34 Visite
  0 Commenti
34 Visite
0 Commenti

Webinar live »Transcranial Pulse Stimulation (TPS) in Patients with Alzheimer`s Disease« mercoledì 24 marzo 2021 · 18:00 - 19:00 (CET)

Webinar live »Transcranial Pulse Stimulation (TPS) in Patients with Alzheimer`s Disease«

Il webinar live »Transcranial Pulse Stimulation (TPS®) in Patients with Alzheimer`s Disease« con il Prof. Dott. Roland Beisteiner sarà offerto da SOTERIX Medical in collaborazione con STORZ MEDICAL.

La stimolazione transcranica a impulsi (TPS®) è una nuova tecnica rivoluzionaria che fornisce una stimolazione a impulsi basata sugli ultrasuoni utilizzando le onde d'urto.

Continua a leggere
0
  55 Visite
  0 Commenti
55 Visite
0 Commenti

Stimolazione transcranica a impulsi (TPS): primo sistema NEUROLITH installato in Svizzera

Primo sistema NEUROLITH installato in Svizzera

La stimolazione transcranica a impulsi (TPS®) per il trattamento dei malati di Alzheimer è ora disponibile anche per i pazienti svizzeri. A febbraio 2021 è stato installato con successo nello studio Alexander Russ di Zurigo il primo sistema NEUROLITH®.

Continua a leggere
0
  78 Visite
  0 Commenti
78 Visite
0 Commenti

Parkinson's disease: World's first clinical trial for shock wave treatment

2020-09-30_news_TPS-enables-targeted-stimulation-of-cerebral-region

In 2019 the NEUROLITH® shock wave system was successfully introduced to the market. The Transcranial Pulse Stimulation (TPS®) device, which was developed by STORZ MEDICAL in Switzerland, is the only medical device marketed in Europe that is approved in the European Union for the treatment of the central nervous system of patients with Alzheimer's disease. The effect of TPS® is now being investigated in another neurological condition: In September 2020, the world's first clinical study for the treatment of Parkinson's patients with shock wave therapy using real-time documentation started at MedUni Vienna (Department of Neurology) in Austria under the direction of Professor Roland Beisteiner.

Continua a leggere
0
  1632 Visite
  0 Commenti
1632 Visite
0 Commenti

NEUROLITH installation: in the treatment of patients with Alzheimer’s disease, the »Rudolfinerhaus Privatklinik« in Vienna, Austria, relies on Transcranial Pulse Stimulation (TPS)

2020-07-20_news_NEUROLITH-Installation-Vienna

Throughout the world, more and more specialised medical centres are using Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system for the treatment of patients with Alzheimer’s disease. In June 2020, another NEUROLITH® system was installed successfully at the private hospital »Rudolfinerhaus Privatklinik« in Vienna, Austria, where it will be used under the medical direction of Dr Matthias Geisler. On-site training of the hospital’s treatment team was carried out by Dr Henning Lohse-Busch (Rheintalklinik, Bad Krozingen, Germany) who also played a decisive role in the development of TPS®.

Continua a leggere
0
  2002 Visite
  0 Commenti
2002 Visite
0 Commenti

Alzheimer’s treatment: study on STORZ MEDICAL’s Transcranial Pulse Stimulation (TPS) is among the top 10% most downloaded papers in Advanced Science

2020-05-26_Top-downloaded-paper

In December 2019, the first study1 on Transcranial Pulse Stimulation (TPS®) with STORZ MEDICAL’s NEUROLITH® system was published in the prestigious journal Advanced Science. In the study, Beisteiner et al. evaluate the TPS® method and present treatment results. The presented data shows that it is possible to improve brain performance with TPS® and that there is a long-term effect.

Continua a leggere
0
  2314 Visite
  0 Commenti
2314 Visite
0 Commenti

STORZ MEDICAL’s NEUROLITH® receives CE approval – Transcranial Pulse Stimulation (TPS) on the central nervous system of patients with Alzheimer’s disease

Neurolith_CE_Approval

In December 2018, STORZ MEDICAL has received the CE approval for the NEUROLITH®, a new therapy system for the treatment of neurological diseases.

Continua a leggere
26
  14625 Visite
  0 Commenti
14625 Visite
0 Commenti
Linkedin Channel Facebook Channel Instagram Channel Twitter Youtube Channel